Cytokine-like 1 regulates cardiac fibrosis via modulation of TGF-β Signaling

Jooyeon Kim, Jihwa Kim, Seung Hee Lee, Sacha V. Kepreotis, Jimeen Yoo, Jang Soo Chun, Roger J. Hajjar, Dongtak Jeong, Woo Jin Park

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Cytokine-like 1 (Cytl1) is a secreted protein that is involved in diverse biological processes. A comparative modeling study indicated that Cytl1 is structurally and functionally similar to monocyte chemoattractant protein 1 (MCP-1). As MCP-1 plays an important role in cardiac fibrosis (CF) and heart failure (HF), we investigated the role of Cytl1 in a mouse model of CF and HF. Cytl1 was upregulated in the failing mouse heart. Pressure overload-induced CF was significantly attenuated in cytl1 knock-out (KO) mice compared to that from wild-type (WT) mice. By contrast, adeno-associated virus (AAV)-mediated overexpression of cytl1 alone led to the development of CF in vivo. The endothelial-mesenchymal transition (EndMT) and the transdifferentiation of fibroblasts (FBs) to myofibroblasts (MFBs) have been suggested to contribute considerably to CF. Adenovirus-mediated overexpression of cytl1 was sufficient to induce these two critical CF-related processes in vitro, which were completely abrogated by co-treatment with SB-431542, an antagonist of TGF-β receptor 1. Cytl1 induced the expression of TGF-β2 both in vivo and in vitro. Antagonizing the receptor for MCP-1, C-C chemokine receptor type 2 (CCR2), with CAS 445479-97-0 did not block the pro-fibrotic activity of Cytl1 in vitro. Collectively, our data suggest that Cytl1 plays an essential role in CF likely through activating the TGF-β-SMAD signaling pathway. Although the receptor for Cyt1l remains to be identified, Cytl1 provides a novel platform for the development of anti-CF therapies.

Original languageEnglish
Article numbere0166480
JournalPLoS ONE
Volume11
Issue number11
DOIs
StatePublished - Nov 2016

Fingerprint

Dive into the research topics of 'Cytokine-like 1 regulates cardiac fibrosis via modulation of TGF-β Signaling'. Together they form a unique fingerprint.

Cite this